Advantech Capital
36
75M
29
4.50
15
0.17
7
- Stages of investment
- Areas of investment
Summary
Advantech Capital is the famous VC, which was founded in 2015.
The current fund was established by Jianming Yu. We also calculated 3 valuable employees in our database.
We can highlight the next thriving fund investment areas, such as Information Technology, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight SenseTime, Zhihu, Qutoutiao. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low.
The fund is generally included in 2-6 deals every year. Opposing the other organizations, this Advantech Capital works on 12 percentage points less the average amount of lead investments. Deals in the range of more than 100 millions dollars are the general things for fund. Speaking about the real fund results, this VC is 41 percentage points more often commits exit comparing to other organizations. The increased amount of exits for fund were in 2019. The typical startup value when the investment from Advantech Capital is more than 1 billion dollars. The top activity for fund was in 2018.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Advantech Capital, startups are often financed by Qiming Venture Partners, IDG Capital, Tencent Holdings. The meaningful sponsors for the fund in investment in the same round are Tencent Holdings, Qiming Venture Partners, OrbiMed. In the next rounds fund is usually obtained by Temasek Holdings, Legend Capital, Alibaba Group.
Investments analytics
Analytics
- Total investments
- 36
- Lead investments
- 15
- Exits
- 7
- Rounds per year
- 4.50
- Follow on index
- 0.17
- Investments by industry
- Biotechnology (17)
- Pharmaceutical (16)
- Health Care (9)
- Medical (8)
- Biopharma (7) Show 51 more
- Investments by region
-
- China (29)
- United States (6)
- Peak activity year
- 2018
- Number of Unicorns
- 2
- Number of Decacorns
- 2
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 316M
- Group Appearance index
- 0.94
- Strategy success index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Boan Biotech | 05 Jan 2021 | Biotechnology, Pharmaceutical, Therapeutics, Product Research | Early Stage Venture | 105M | Liaoning, Yantai, China |
| Onconano Medicine | 17 Jun 2021 | Biotechnology, Health Care, Nanotechnology, Alternative Medicine | Early Stage Venture | 50M | United States, Texas, Dallas |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.